title: Clinical use of the somatostatin analog SMS 201-995 in endocrinology.
authors.affiliation: Divisione di Endocrinologia, Ospedale Niguarda, Milano, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Cozzi
authors.forename: A
authors.initials: A
authors.lastname: Liuzzi
authors.forename: D
authors.initials: D
authors.lastname: Dallabonzana
authors.forename: G
authors.initials: G
authors.lastname: Oppizzi
authors.forename: P
authors.initials: P
authors.lastname: Orlandi
authors.forename: C
authors.initials: C
authors.lastname: De Palo
authors.forename: M M
authors.initials: MM
authors.lastname: Petroncini
authors.forename: M
authors.initials: M
authors.lastname: Piolini
authors.forename: P G
authors.initials: PG
authors.lastname: Chiodini
mesh_terms: D000172:Acromegaly / Q000188:drug therapy; D007516:Adenoma, Islet Cell / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D004700:Endocrine System Diseases / Q000188:drug therapy*; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D010911:Pituitary Neoplasms / Q000188:drug therapy; D013972:Thyrotropin / Q000378:metabolism
chemical_list: D013972:Thyrotropin; D015282:Octreotide